New Key Statistics Module, Z-Score and F-Score
NAS:LPCN Key Ratios
| Market Cap $ M | 41.87 |
| Enterprise Value $ M | 17.24 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.74 |
| Price/Sales | 8.66 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4.00 |
| EPS (TTM) $ | -1.71 |
| Beneish M-Score | 41.9 |
| 10-y EBITDA Growth Rate % | 28.40 |
| 5-y EBITDA Growth Rate % | 32.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.71 |
| EV-to-EBITDA | -1.71 |
| PEG | -- |
| Shares Outstanding M | 5.35 |
| Net Margin (%) | -190.36 |
| Operating Margin % | -220.10 |
| Pre-tax Margin (%) | -190.36 |
| Quick Ratio | 16.99 |
| Current Ratio | 16.99 |
| ROA % (ttm) | -32.56 |
| ROE % (ttm) | -35.22 |
| ROIC % (ttm) | -711.26 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.63 |
LPCN Number of Guru Trades
LPCN Volume of Guru Trades
Gurus Latest Trades with NAS:LPCN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LPCN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lipocine Inc Insider Transactions
No Available Data
News about NAS:LPCN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers